MarketCapTrends
DGX
Quest Diagnostics Inc. (DGX)
NYSE · Healthcare

Quest Diagnostics Inc. Shareholder Equity 2007–2025

Quest Diagnostics Inc. annual/quarterly shareholder equity history from 2008 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Quest Diagnostics Inc. shareholder equity for the quarter ending December 31, 2025 were 7.17B, a 5.78% increase year-over-year.
  • Quest Diagnostics Inc. shareholder equity for 2025 were 7.17B, a 5.78% increase from 2024.
  • Quest Diagnostics Inc. shareholder equity for 2024 were 6.78B, a 7.47% increase from 2023.
  • Quest Diagnostics Inc. shareholder equity for 2023 were 6.31B, a 7.03% increase from 2022.
  • Quest Diagnostics Inc. shareholder equity for 2022 were 5.89B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Quest Diagnostics Inc. Annual Shareholder Equity (Millions of US $)
2025$7,170
2024$6,778
2023$6,307
2022$5,893
2021$6,444
2020$6,759
2019$5,641
2018$5,216
2017$4,921
2016$4,628
2015$4,684
2014$4,301
2013$3,948
2012$4,163
2011$3,693
Quest Diagnostics Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$7,170
2024-12-31$6,778
2023-12-31$6,307
2022-12-31$5,893
2021-12-31$6,444
2020-12-31$6,759
2019-12-31$5,641
2018-12-31$5,216
2017-12-31$4,921
2016-12-31$4,628
2015-12-31$4,684
2014-12-31$4,301
2013-12-31$3,948
2012-12-31$4,163
2011-12-31$3,693
2010-12-31$4,033
2009-12-31$3,990
2008-12-31$3,605

Quest Diagnostics Inc. Shareholder Equity — FAQ

Quest Diagnostics Inc. (DGX) shareholder equity over the last 19 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see DGX's shareholder equity history?

The chart and table above show Quest Diagnostics Inc.'s shareholder equity by year and by quarter, including the growth rate.